Ets proteins in biological control and cancer

Journal of Cellular Biochemistry

Volumn 91, Issue 5, 2004, Pages 896-903

  Hsu, Tien ^a   Trojanowska, Maria ^a   Watson, Dennis K ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cancer; ECM; EMT; Epithelium; Ets; Invasion; Metastasis; Stroma; Transcriptional regulation

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS; DNA BINDING PROTEIN; ELF2 PROTEIN, HUMAN; ETS2 PROTEIN, HUMAN; ETV1 PROTEIN, HUMAN; ONCOPROTEIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR ELK 1; TRANSCRIPTION FACTOR ETS 2;

ARTICLE; CANCER; CELL FUNCTION; CELL INTERACTION; DNA SEQUENCE; EPITHELIUM; GENE FUNCTION; IN VIVO STUDY; MESENCHYME; METASTASIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FAMILY; STROMA CELL; TUMOR CELL; TUMOR GROWTH; ANIMAL; BIOLOGICAL MODEL; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL MOTION; GENE EXPRESSION; GENETICS; HUMAN; MULTIGENE FAMILY; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL MOVEMENT; DNA-BINDING PROTEINS; ETS-DOMAIN PROTEIN ELK-1; GENE EXPRESSION; HUMANS; MODELS, BIOLOGICAL; MULTIGENE FAMILY; NEOPLASMS; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEIN C-ETS-2; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 4544353968     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20012     Document Type: Article

References (35)

1. Aplin AE, Stewart SA, Assoian RK, Juliano RL. 2001. Integrin-mediated adhesion regulates ERK nuclear translocation and phosphorylation of Elk-1. J Cell Biol 153:273-282.
2. Bartel FO, Higuchi T, Spyropoulos DD. 2000. Mouse models in the study of the Ets family of transcription factors. Oncogene 19:6443-6454.
3. Bissell MJ, Radisky D. 2001. Putting tumours in context. Nat Rev Cancer 1:46-54.
4. Bissell MJ, Radisky DC, Rizki A, Weaver VM, Petersen OW. 2002. The organizing principle: Microenvironmental influences in the normal and malignant breast. Differentiation 70:537-546.
5. Comoglio PM, Boccaccio C, Trusolino L. 2003. Interactions between growth factor receptors and adhesion molecules: Breaking the rules. Curr Opin Cell Biol 15:565-571.
6. Czuwara-Ladykowska J, Shirasaki F, Jackers P, Watson DK, Trojanowska M. 2001. Fli-1 inhibits collagen type I production in dermal fibroblasts via an Sp1-dependent pathway. J Biol Chem 276:20839-20848.
7. Czuwara-Ladykowska J, Sementchenko VI, Watson DK, Trojanowska M. 2002. Etsl is an effector of the transforming growth factor beta (TGF-beta) signaling pathway and an antagonist of the profibrotic effects of TGF- beta. J Biol Chem 277:20399-20408.
8. Dittmer J. 2003. The biology of the Etsl proto-oncogene. Mol Cancer 2:29-49.
9. Elvert G, Kappel A, Heidenreich R, Englmeier U, Lanz S, Acker T, Rauter M, Plate K, Sieweke M, Breier G, Flamme I. 2002. Cooperative interaction of hypoxia inducible factor (HIF)-2a and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor-2 (Flk-1). J Biol Chem 278:7520-7530.
10. Feldman RJ, Sementchenko VI, Gayed M, Fraig MM, Watson DK. 2003. Pdef expression in human breast cancer is correlated with invasive potential and altered gene expression. Cancer Res 63:4626-4631.
11. Goel A, Janknecht R. 2003. Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P/CAF, and HER2/Neu. Mol Cell Biol 23:6243-6254.
12. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100:57-70.
13. Hart A, Melet F, Grossfeld P, Chien K, Jones C, Tunnacliffe A, Favier R, Bernstein A. 2000. Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity 13:167-177.
14. Hebert JM, Rosenquist T, Gotz J, Martin GR. 1994. FGF5 as a regulator of the hair growth cycle: Evidence from targeted and spontaneous mutations. Cell 78:1017-1025.
15. Jinnin M, Ihn H, Asano Y, Yamane K, Trojanowska M, Tamaki K. Tenascin-C upregulation by TGF-β in human dermal fibroblasts involves Smad3, Sp1 and Ets1. Oncogene (in press).
16. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C, Guise TA, Massague J. 2003. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3:537-549.
17. Kawada H, Ito T, Pharr PN, Spyropoulos DD, Watson DK, Ogawa M. 2001. Defective megakaryopoiesis and abnormal erythroid development in Fli-1 gene-targeted mice. Int J Hematol 73:463-468.
18. Klappacher GW, Lunyak W, Sykes DB, Sawka-Verhelle D, Sage J, Brard G, Ngo SD, Gangadharan D, Jacks T, Kamps MP, Rose DW, Rosenfeld MG, Glass CK. 2002. An induced Ets repressor complex regulates growth arrest during terminal macrophage differentiation. Cell 109:169-180.
19. Kubo M, Czuwara-Ladykowska J, Moussa O, Markiewicz M, Smith E, Silver RM, Jablonska S, Blaszczyk M, Watson DK, Trojanowska M. 2003. Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin. Am J Pathol 163:571-581.
20. Lavenburg KR, Ivey J, Hsu T, Muise-Helmericks RC. 2003. Coordinated functions of Akt/PKB and ETS1 in tubule formation. Faseb J 17:2278-2280.
21. Li R, Pei H, Watson DK 2000a. Regulation of Ets function by protein-protein interactions. Oncogene 19:6514-6523.
22. Li R, Pei H, Watson DK, Papas TS. 2000b. EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes. Oncogene 19:745-753.
23. Liotta LA, Kohn EC. 2001. The microenvironment of the tumour-host interface. Nature 411:375-379.
24. Mareel M, Leroy A. 2003. Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev 83:337-376.
25. Moussad EE, Brigstock DR. 2000. Connective tissue growth factor: What's in a name? Mol Genet Metab 71:276-292.
26. Oikawa T, Yamada T. 2003. Molecular biology of the Ets family of transcription factors. Gene 303:11-34.
27. Poei H, Yordy JS, Leng Q, Zhao Q, Watson DK. 2003. EAPII interacts with Ets1 and modulates its transcriptional function. Oncogene 22:2699-2709.
28. Rebay I, Chen F, Hsiao F, Kolodziej PA, Kuang BH, Laverty T, Suh C, Voas M, Williams A, Rubin GM. 2000. A genetic screen for novel components of the Ras/Mitogen-activated protein kinase signaling pathway that interact with the yan gene of Drosophila identifies split ends, a new RNA recognition motif- containing protein. Genetics 154:695-712.
29. Sementchenko VI, Watson DK. 2000. Ets target genes: Past, present, and future. Oncogene 19:6533-6548.
30. Shirasaki F, Makhulf HA, LeRoy C, Watson DK, Trojanowska M. 1999. Ets transcription factors cooperate with Sp1 to activate the human tenascin-C promoter. Oncogene 18:7755-7764.
31. Thiery JP. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2:442-454.
32. Watson DK, Seth A. 2000. Ets gene family. In: Jenkins J, Reddy EP, editors. "Oncogene reviews." London: Nature Publishing Group, pp 6393-6548.
33. Watson DK, Li R, Sementchenko VI, Mavrothalassitis G, Seth A. 2001. The ETS genes. In: Bertino JR, editor. "Encyclopedia of cancer." San Diego: Academic Press. pp 189-196.
34. Wells J, Farnham PJ. 2002. Characterizing transcription factor binding sites using formaldehyde crosslinking and immunoprecipitation. Methods 26:48-56.
35. Yordy JS, Muise-Helmericks RC. 2000. Signal transduction and the Ets family of transcription factors. Oncogene 19:6503-6513.